Loading the security overview…
Where the tokens are
Where the tokens are
Key statistics
technicals as of Oct 2, 2026- Market cap
- $25.64B
- P/E
- —EPS -$0.37
- 52-week range
- $14.86 – $42.50price at 75% of range
- Volume
- 3.4Maverage day 8.96M
- Previous close
- $35.50
- P/S
- 3404.5
- P/B
- 6.1
- Dividend yield
- 0.00%
- Next ex-dividend
- —
- Next earnings
- Nov 9before the open
- Beta
- 0.5590 days, against SPY
- RSI (14)
- 42.1as of Oct 2
Figures describe Roivant Sciences shares, not any token.
Every tokenized version
Search and filter all tokensEach row is one issuer’s token for Roivant Sciences, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.
| Token | Issuer | Chains | You hold |
|---|---|---|---|
ROIVx |  xStocks | TONINKSOLMNTHYPEETHBNBXLYRARBOP | — |
Deployments come from the instrument registry, generated 2026-09-30. A chain listed here is one the issuer has deployed on, not a promise that a market exists on it.
About Roivant Sciences Ltd. Common Shares
roivant.comRoivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
- Type
- Common stock
- Sector
- Healthcare › Biotechnology
- Exchange
- Nasdaq
- Listed since
- Oct 1, 2021
- Shares outstanding
- 722.32M
- Employees
- 721
As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.
